Absci (ABSI) Minority Interest (2020 - 2021)

Absci (ABSI) reported Minority Interest of $161.4 million for Q2 2021, up 3.16% sequentially from $156.4 million in Q4 2020.

Absci (ABSI) Minority Interest (2020 - 2021) Analysis & Trends

Absci (ABSI) has 2 years of Minority Interest data on file, last reported at $161.4 million in Q2 2021.

For the quarter ending Q2 2021, Minority Interest changed N/A year-over-year to $161.4 million; the trailing twelve-month figure through Jun 2021 stood at $161.4 million (changed N/A YoY), and the FY2020 full-year result was $156.4 million, changed N/A from the prior year.
Minority Interest grew to $161.4 million in Q2 2021, from $156.4 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $161.4 million in Q2 2021 to a low of $156.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Absci	1.23 Bn	1.11 Bn	-

Download Data

Date	Value
Jun 30, 2021	161.38 Mn
Dec 31, 2020	156.43 Mn